Reply to F. Muntoni et al.: “In response to P.R. Clemens et al., Efficacy and Safety of Viltolarsen in Boys with Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study, and Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy

Detalles Bibliográficos
Autores principales: Clemens, Paula R., Hoffman, Eric P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Reply to the Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657699/
https://www.ncbi.nlm.nih.gov/pubmed/37955094
http://dx.doi.org/10.3233/JND-239005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657699/
https://www.ncbi.nlm.nih.gov/pubmed/37955094
http://dx.doi.org/10.3233/JND-239005

Ejemplares similares